Pierre Fabre Set To Shake Up EU Melanoma Market

 
• By Kevin Grogan

Having just got the nod for the combination of Braftovi and Mektovi, the French company believes the strength of its overall survival data will see the therapy successfully compete with other BRAF/MEK combos and immunotherapies for melanoma.

Airplanes
Pierre Fabre lines up launches for melanoma combo • Source: Shutterstock

More from Archive

More from Scrip